Single metatarsal percutaneous distal metatarsal osteotomy (DMMO) for 3rd space morton neuroma is safe and

Alirio J deMeireles1, Mariano de Prado2,3,4,5, Jamie Confino1

  • 1Columbia University Irving Medical Center, New York, NY, USA.

Abstract

Insights

A novel surgical technique for Morton's interdigital neuroma (MN) significantly improved patient outcomes. This minimally invasive approach offers effective relief for foot pain, enhancing function and quality of life.

Area of Science:

  • Orthopedic Surgery
  • Podiatric Medicine
  • Neurology

Background:

  • Morton's interdigital neuroma (MN) is a prevalent nerve compression issue in the foot.
  • Current treatments often fail, necessitating surgical intervention.

Purpose of the Study:

  • To evaluate the outcomes of a modified distal minimally invasive metatarsal osteotomy (DMMO) for treating Morton's neuroma.
  • To assess the efficacy of a novel surgical technique in improving patient-reported outcomes.

Main Methods:

  • Retrospective review of 25 patients with confirmed Morton's neuroma.
  • Surgical intervention involved DMMO of the 4th metatarsal and deep transverse intermetatarsal ligament release.
  • Patient-reported outcome measures (PROMs) including VAS and FFI were assessed at minimum one-year follow-up.

Main Results:

  • Significant improvements were observed in all PROMs post-surgery.
  • Mean VAS scores decreased from 7.35 to 0.41 (p < 0.001).
  • Mean FFI Total scores reduced from 57.5 to 17.2 (p < 0.001), with significant decreases in all sub-scores.

Conclusions:

  • The modified DMMO technique demonstrates significant efficacy in improving patient-reported outcomes for Morton's neuroma.
  • Treatment success was independent of neuroma size, patient sex, or comorbidities.
  • This minimally invasive approach provides a viable surgical option for refractory Morton's neuroma.

Related Concept Videos